European Journal of Clinical Pharmacology

Article	Citations
How to make the best of NLRP3 inhibitors in patients with COVID-19?	92
Might chronic spontaneous urticaria develop after SARS-CoV-2 vaccinations?	35
A Study Of the effect of Sex on drug dosing, concentrations, and pharmacogenomics in the Montreal Heart Institute Hospital Cohort (SOS-PGx): methodology and research progress	34
Medication adherence among persons with coronary heart disease and associations with blood pressure and low-density-lipoprotein-cholesterol	33
Association study identifies genetic determinants and non-genetic factors on steady-state plasma and therapeutic outcome of galantamine in mixed dementia	30
Anticholinergic burden and cognitive performance: cross-sectional results from the ELSA-Brasil study	30
Use of overactive bladder anticholinergic medications associated with falls leading to emergency department visits: results from the ADRED study	26
A phase 1 study in healthy participants to characterize the safety and pharmacology of inclacumab, a fully human anti-P-selectin antibody, in development for treatment of sickle cell disease	25
Usefulness of mirtazapine and SSRIs in late-life depression: post hoc analysis of the GUNDAM study	25
Recommendations for the safe use of direct oral anticoagulants in patients with cirrhosis based on a systematic review of pharmacokinetic, pharmacodynamic and safety data	24
Incidence and risk factors of drug-induced kidney injury in children: a systematic review and meta-analysis	24
The efficacy and safety of direct oral anticoagulants versus vitamin K antagonists in patients with left-sided bioprosthetic heart valves and atrial fibrillation: a systematic review and meta-analysis	22
Assessment of body mass-related covariates for rifampicin pharmacokinetics in healthy Caucasian volunteers	22
Effects of sodium-glucose cotransporter 2 inhibitors on renal risk factors in patients with abnormal glucose metabolism: a meta-analysis of randomized controlled trials	22
Evaluation of CYP2C19 activity using microdosed oral omeprazole in humans	21
Pharmacoepidemiological methods for computing the duration of pharmacological prescriptions using secondary data sources	20
Self-reported adherence to direct oral anticoagulants versus warfarin therapy in a specialized thrombosis service—a cross-sectional study of patients in a Canadian Health Region	20
Comment on “Use of statins and risks of ovarian, uterine, and cervical diseases: a cohort study in the UK Biobank”	20
Prevalence, contributory factors and severity of medication errors associated with direct-acting oral anticoagulants in adult patients: a systematic review and meta-analysis	19
Relationship between CYP2C8, UGT1A1, and ABCG2 gene polymorphisms and the exposure, efficacy, and toxicity of eltrombopag in the treatment of refractory aplastic anemia	18
Clinical pharmacology—how it shapes the drug development journey	18
Challenges of pediatric pharmacotherapy: A narrative review of pharmacokinetics, pharmacodynamics, and pharmacogenetics	18
Dose selection for aztreonam-avibactam, including adjustments for renal impairment, for Phase IIa and Phase III evaluation	18
Pharmacokinetics of mycophenolic acid and external evaluation of two limited sampling strategies of drug exposure in patients with juvenile systematic lupus erythematosus	18
Dose reduction and discontinuation due to the combination of CDK4/6 inhibitors and endocrine drugs: a systematic review and meta-analysis	17

Retrospective review of intermittent and continuous infusion vancomycin for methicillin-resistant Staphylococcus aureus bacteremia	17
Effect of GLP-1R rs2254336 and rs3765467 polymorphisms on gastrointestinal adverse reactions in type 2 diabetes patients treated with liraglutide	17
Incidence of hospital contacts with acute kidney injury after initiation of second-generation antipsychotics in older adults: a Danish population-based cohort study	16
Ethnicity evaluation of ferric pyrophosphate citrate among Asian and Non-Asian populations: a population pharmacokinetics analysis	16
Effect of dapagliflozin on malignant ventricular arrhythmias in elderly after acute myocardial infarction: a propensity score-matched cohort study	16
Effect of timing of administration on lipid-lowering efficacy of statins-meta-analysis	16
Disproportionality analysis from World Health Organization data on migraine-specific medications and cerebrovascular diseases	16
The contribution of genotype-guided selection of P2Y12 inhibitor on prognosis in ACS /CCS patients undergoing percutaneous coronary intervention: a retrospective cohort study	16
Oral mannitol for bowel preparation: a dose-finding phase II study	16
Purine xanthine oxidase inhibitors are not conducive to the prognosis of chronic heart failure: a meta-analysis	16
Clinical pharmacokinetics and pharmacodynamics of ivosidenib in Chinese patients with relapsed or refractory IDH1-mutated acute myeloid leukemia	16
Anticoagulants in adult extracorporeal membrane oxygenation: alternatives to standardized anticoagulation with unfractionated heparin	16
Patient involvement in pharmacovigilance: determinants and evolution of reporting from 2011 to 2020 in France	16
Mechanisms of landiolol-mediated positive inotropy in critical care settings	15
Cardiovascular medications used for comorbid diseases in patients with atrial fibrillation. The JoFib study	15
ChatGPT for generating multiple-choice questions: comment	15
Analgesic potential of transdermal nicotine patch in surgery: a systematic review and meta-analysis of randomised placebo-controlled trials	15
Risk assessment tools for QT prolonging pharmacotherapy in older adults: a systematic review	15
Evaluating the safety and effectiveness of tolvaptan in patients with heart failure and renal impairment: a systematic review and meta-analysis	15
The beneficial use of nitric oxide during cardiopulmonary bypass on postoperative outcomes in children and adult patients: a systematic review and meta-analysis of 2897 patients	15
Correction to: The risk of congenital heart defects associated with corticosteroids use during the first trimester of pregnancy: a systematic review and meta‑analysis	15
Voriconazole therapeutic drug monitoring including analysis of CYP2C19 phenotype in immunocompromised pediatric patients with invasive fungal infections	14
Correction to: Analgesic effect of oral paracetamol 1000 mg/ibuprofen 400 mg, paracetamol 1000 mg/codeine 60 mg, paracetamol 1000 mg/ibuprofen 400 mg/codeine 60 mg, or placebo on acute postoperative p	14
Does aspirin have an effect on risk of death in patients with COVID-19? A meta-analysis	14
A cocktail probe approach to evaluate the effect of hormones on the expression and activity of CYP enzymes in human hepatocytes with conditions simulating late stage of pregnancy	14
Activities of clinical pharmacologists across Europe: A survey by the European association of clinical pharmacology and therapeutics	14
Rating scales to measure adverse effects of medications in people with intellectual disability: a scoping review	14
Exploring heterogeneities of cardiovascular efficacy and effectiveness of SGLT2 inhibitors in patients with type 2 diabetes: an umbrella review of evidence from randomized clinical trials versus real-	14
Abuse, dependence and withdrawal associated with fentanyl and the role of its (designated) route of administration: an analysis of spontaneous reports from Europe	14
ChatGPT for generating multiple-choice questions: Evidence on the use of artificial intelligence in automatic item generation for a rational pharmacotherapy exam	13
Proton pump inhibitor use: systematic review of global trends and practices	13
Efficacy of tacrolimus versus cyclosporine after lung transplantation: an updated systematic review, meta-analysis, and trial sequential analysis of randomized controlled trials	13
Systemic quinolones and risk of retinal detachment III: a nested case–control study using a US electronic health records database	13
Posting of clinical trial results and other critical information from completed medicines trials on ClinicalTrials.gov	13
Statin treatment for primary and secondary prevention in elderly patients—a cross-sectional study in Stockholm, Sweden	13
Peripheral edema induced by isosorbide mononitrate in an elderly patient: A case study of dose-related risks and drug interactions	12
Effect of metoprolol exposure following myocardial infarction on future cardiovascular events: a Mendelian randomization study	12
Imatinib pharmacokinetics and creatine kinase levels in chronic myeloid leukemia patients: implications for therapeutic response and monitoring	12
Grade ≥ 3 hematologic adverse events of immunotherapy in advanced NSCLC patients: a systematic review and meta-analysis	12
Tramadol and the risk of bleeding complications in patients on oral anticoagulants: a pharmacovigilance study	12
Will artificial intelligence chatbots replace clinical pharmacologists? An exploratory study in clinical practice	11
Nitrofurantoin for the treatment of uncomplicated urinary tract infection in female patients: the impact of dosing regimen, age, and renal function on drug exposure	11
GLP 1 receptor agonists and obesity-associated cancers: a disproportionality analysis in Vigibase®	11
Safety profile of COVID-19 drugs in a real clinical setting	11
A novel physiologically-based pharmacokinetic model to estimate reduced CYP3A4 activity in cancer patients utilizing the neutrophil-to-lymphocyte ratio as an inflammatory marker	11
Risk factors for thrombocytopenia in patients receiving linezolid therapy: a systematic review and meta-analysis	11
Evaluation of pharmacogenomics and hepatic nuclear imaging–related covariates by population pharmacokinetic models of irinotecan and its metabolites	11
Risk of gastric cancer among long-term proton pump inhibitor users: a population-based cohort study	11
Assessment of severity and avoidability of adverse drug reactions in neonates: a reproducibility study of the Hartwig tool and LAAT	11
Effectiveness and safety of vonoprazan-based regimens compared with those of proton pump inhibitor (PPI)–based regimens as first-line agents for Helicobacter pylori: a meta-analysis of randomized clin	11

No evidence of clinical efficacy of oxomemazine in cough, according to a systematic review	11
Spikevax booster and delayed urticaria: a Swiss signal with diagnostic uncertainties due to a high proportion of direct patient reports	11
Pharmacotherapy of Alzheimer’s disease: an overview of systematic reviews	11
Correction to: Use of antibiotics in the early COVID‑19 pandemic in Poland, the Netherlands and Spain, from erraticism to (more) logic	10
Meta-analysis of the associations of IMPDH and UGT1A9 polymorphisms with rejection in kidney transplant recipients taking mycophenolic acid	10
Patterns of inappropriate prescribing and clinical characteristics in patients at admission to an acute care of the elderly unit	10
Physiologically based pharmacokinetic model predictions of natural product-drug interactions between goldenseal, berberine, imatinib and bosutinib	10
Oxytocin treatment for core symptoms in children with autism spectrum disorder: a systematic review and meta-analysis	10
Facilitators and barriers to generic and biosimilar medications in the Middle East and North Africa: insights from physicians and pharmacists—a systematic review	10
Incremental net benefit of lipid-lowering therapy with PCSK9 inhibitors: a systematic review and meta-analysis of cost-utility studies	10
Serum concentrations of antidepressants, antipsychotics, and antiepileptics over the bariatric surgery procedure	10
Estimated equipotent conversion ratios of morphine, sufentanil and fentanyl as continuous infusion in neonatal intensive care units: a pharmacoepidemiologic cohort study	10
Clinical and biochemical characteristics, and outcome in 33 patients with ceftriaxone-induced liver injury	10
Understanding hemoglobin contribution to high-dose methotrexate disposition—population pharmacokinetics in pediatric patients with hematological malignancies	10
Severe CNS depression with duloxetine, ciprofloxacin and CYP2D6 deficiency—role and recognition of drug-drug-gene interactions	10
ChatGPT for generating multiple-choice questions: a reply	10
Acid suppressant use in association with incidence and severe outcomes of COVID-19: a systematic review and meta-analysis	10
Perception of pharmacological equivalence of generics or biosimilars in healthcare professionals in Vienna	10
Teaching rational prescribing in undergraduate medical education: a systematic search and review	10
Could carbamazepine-acetazolamide interaction lead to a severe hepatocellular liver injury? an interaction that needs to be uncovered	10
The effect of potent CYP2D6 inhibition on the pharmacokinetics and safety of deutetrabenazine in healthy volunteers	10
Selective serotonin reuptake inhibitors use and the risk of hepatocellular carcinoma: a systematic review and dose–response analysis of cohort studies with one million participants	9
Pharmacological interventions for preventing atrial fibrillation after lung surgery: systematic review and meta-analysis	9
A standard dose of linezolid puts patients with hepatic impairment at risk of overexposure	9
Tacrolimus improved the pregnancy outcomes of patients with refractory recurrent spontaneous abortion and immune bias disorders: a randomized controlled trial	9
Does evidence from RCTs suggest: SGLT2 inhibitors could not reduce myocardial infarction and stroke?	9
Impact of histamine-2 antagonist shortage on the incidence of hypersensitivity reactions to paclitaxel: a reconsideration of premedication protocols in France (PACLIREACT Study)	9
Physicochemical compatibility of caffeine citrate and caffeine base injections with parenteral medications used in neonatal intensive care settings	9
Population pharmacokinetics of bedaquiline: a systematic review	9
The impact of enteric coating of aspirin on aspirin responsiveness in patients with suspected or newly diagnosed ischemic stroke: prospective cohort study: results from the (ECASIS) study	9
Analgesic effect of oral paracetamol 1000 mg/ibuprofen 400 mg, paracetamol 1000 mg/codeine 60 mg, paracetamol 1000 mg/ibuprofen 400 mg/codeine 60 mg, or placebo on acute postoperative pain: a single-d	9
Serum trough concentration threshold and risk factors of cefoperazone-induced coagulopathy in critically ill patients: A retrospective case-control study	9
Why we should not recommend or offer fluvoxamine to COVID-19 patients?	8
Non-persistence to antihypertensive drug therapy in Lithuania	8
Perception of clinical research among patients and healthy volunteers of clinical trials	8
Trends in use of sodium-glucose co-transporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA) in Australia in the era of increased evidence of their cardiovascular benef	8
Assessing the binding interaction of polystyrene sulfonate with amitriptyline in healthy volunteers: a cross-over design — The BIND study	8
High refill-adherence to adalimumab is associated with low disease activity in patients with inflammatory bowel disease	8
Effects of dapagliflozin and empagliflozin on 6-min walk distance in heart failure with preserved and reduced ejection fraction: A systematic review and meta-analysis of randomized controlled trials i	8
Therapeutic drug monitoring as an essential tool to ensure clozapine efficacy and prevent its toxicity in smokers: a case report	8
Pharmacogenetics of opioid medications for relief of labor pain and post-cesarean pain: a systematic review and meta-analysis	8
Adjuvant use of melatonin for relieving symptoms of painful diabetic neuropathy: results of a randomized, double-blinded, controlled trial	8
Effect of propranolol on pharmacokinetics of clozapine in schizophrenic patients: a meta-analysis	8
A collaborative study of the impact of N-nitrosamines presence and ARB recall on ARB utilization – results from IQVIA™ Disease Analyzer Germany	8
Inhalation therapies in COPD — adverse drug reactions impact on emergency department presentations	8
Impact of CYP2D6*2, CYP2D6*35, rs5758550, and related haplotypes on risperidone clearance in vivo	8
Correlations between 4β-hydroxycholesterol and hepatic and intestinal CYP3A4: protein expression, microsomal ex vivo activity, and in vivo activity in patients with a wide body weight range	8
Hospitalisations related to benzodiazepine, Z-drug, and opioid treatment in Italy: a claim on the risks associated with inappropriate use	8
Efficacy and safety of nitazoxanide in treating SARS-CoV-2 infection: a systematic review and meta-analysis of blinded, placebo-controlled, randomized clinical trials	8
Population plasma and urine pharmacokinetics and the probability of target attainment of fosfomycin in healthy male volunteers	8
Estimating the impact of label design on reducing the risk of medication errors by applying HEART in drug administration	8
Characteristics of isoniazid-induced psychosis: a systematic review of case reports and case series	8
Impact of tofogliflozin on hepatic outcomes: a systematic review	8
Influence of metformin on hyperandrogenism in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized clinical trials	8
Approaches for posaconazole therapeutic drug monitoring and their clinical benefits	8
Coenzyme Q10 as a potential add-on treatment for patients suffering from painful diabetic neuropathy: results of a placebo-controlled randomized trial	8
Real-world safety and effectiveness of pirfenidone and nintedanib in the treatment of idiopathic pulmonary fibrosis: a systematic review and meta-analysis	7
Drug utilisation in neonatal units in England and Wales: a national cohort study	7
Optimisation of warfarin-dosing algorithms for Han Chinese patients with CYP2C9*13 variants	7
Author’s reply to the letter to the editor: “Effects of dapagliflozin and empagliflozin on 6‑min walk distance in heart failure with preserved and reduced ejection fraction: A systematic review and me	7
15th Congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT)	7
Influence of cigarette smoking on drugs’ metabolism and effects: a systematic review	7
Factors influencing methotrexate pharmacokinetics highlight the need for individualized dose adjustment: a systematic review	7
JAK inhibitors and risk of major cardiovascular events or venous thromboembolism: a self-controlled case series study	7
Association between antidepressant use and gynecological cancer risk: a systematic review and meta-analysis	7
The effect of preoperative statin treatment on acute kidney injury in elderly patients undergoing valve replacement surgery	7
Man vs. machine: comparison of pharmacogenetic expert counselling with a clinical medication support system in a study with 200 genotyped patients	7
Impact of trough abiraterone level on adverse events in patients with prostate cancer treated with abiraterone acetate	7
The safety and efficacy of bevacizumab in treatment of recurrent low-grade glioma: a systematic review and meta-analysis	7
Applying pharmacokinetic/pharmacodynamic measurements for linezolid in critically ill patients: optimizing efficacy and reducing resistance occurrence	7
Predictive Role of Serotonin Receptor (5HTR2A) and Dopamine Receptor (DRD2) gene polymorphisms in risperidone-induced weight gain and hyperprolactinemia in patients with schizophrenia	7
The effect of concomitant use of proton pump inhibitors with CDK 4/6 inhibitors on survival in metastatic breast cancer	7
Effects of mirabegron on brown adipose tissue and metabolism in humans: A systematic review and meta-analysis	7
Evaluation of pharmacological interventions in the management of adenomyosis: a systematic review	7
Relationship between elevated bilirubin levels and enhanced warfarin effects during biliary obstruction	7
Pharmacokinetics of nirmatrelvir/ritonavir and the drug-drug interaction with calcineurin inhibitor in renal transplant recipients	7
Duplicate prescriptions in the emergency department: a retrospective cohort study	7
Era of surrogate endpoints and accelerated approvals: a comprehensive review on applicability, uncertainties, and challenges from regulatory, payer, and patient perspectives	7
Effects of oral antidiabetic agents on the renin–angiotensin–aldosterone system	7
ACD856, a novel positive allosteric modulator of Trk receptors, single ascending doses in healthy subjects: Safety and pharmacokinetics	7

Time-dependent association between omeprazole and esomeprazole and hospitalization due to hyponatremia	6
Correction to: Potentially inappropriate medications and cognitive performance: cross‑sectional results from the ELSA–Brasil study	6
Efficacy of cannabis-based medicine in the treatment of Tourette syndrome: a systematic review and meta-analysis	6
Aspirin in people with dementia	6
External evaluation of published population pharmacokinetic models of polymyxin B	6
Statins in Alzheimer’s disease (AD)	6
A genetic-based population PK/PD modeling of methadone in Chinese opiate dependence patients	6
Dose-dependent effect of lamotrigine on quetiapine serum concentration in patients using instant release tablets	6
Prescribing patterns of glucagon-like peptide-1 receptor agonists in the Swedish capital region—a register-based cross-sectional study	6
Effects of active vitamin D analogs and calcimimetic agents on PTH and bone mineral biomarkers in hemodialysis patients with SHPT: a network meta-analysis	6
Area under the curve of tacrolimus using microsampling devices: towards precision medicine in solid organ transplantation?	6
Pharmacokinetics-pharmacodynamics of first-line antitubercular drugs: a comparative study in tuberculosis patients with and without concomitant diabetes mellitus	6
A view of response and resistance to atomoxetine treatment in children with ADHD: effects of CYP2C19 polymorphisms and BDNF levels	6
Factors predicting clinical and endoscopic remission with placebo therapy in East Asian patients with ulcerative colitis: a systematic review and meta-analysis	6
Effect of gene polymorphism on bleeding complications in Chinese Han patients taking warfarin	6
Hypertension and Covid-19 vaccines: are there any differences between the different vaccines? A safety signal	6
Application of machine learning to predict tacrolimus exposure in liver and kidney transplant patients given the MeltDose formulation	6
Educational value of international and intercultural differences in prescribing: the international and interprofessional student-run clinic project	6
Validating the accuracy of mathematical model–based pharmacogenomics dose prediction with real-world data	6
Effect of digoxin on all-cause and cardiovascular mortality in patients with atrial fibrillation with and without heart failure: an umbrella review of systematic reviews and 12 meta-analyses	6
COVID-19 and pregnancy: A European study on pre- and post-infection medication use	6
Letter to the editor: "Effects of dapagliflozin and empagliflozin on 6-min walk distance in heart failure with preserved and reduced ejection fraction: a systematic review and meta-analysis of randomi	6
Efficacy and safety of ramucirumab for gastric or gastro-esophageal junction adenocarcinoma: a systematic review and meta-analysis	6
Risk of agranulocytosis with metamizole in comparison with alternative medications based on health records in Spain	6
Effectiveness and safety of gonadotropins used in female infertility: a population-based study in the Lazio region, Italy	5
Maternal paracetamol intake and fetal ductus arteriosus closure: adding pieces to the scenery	5
Apixaban plasma concentrations in patients with obesity	5
Effects of olanzapine in the improvement of body weight and appetite in patients with cancer or receiving chemotherapy: a systematic review and meta-analysis	5
Long-term outcomes of statin dose, class, and use intensity on primary prevention of cardiovascular mortality: a national T2DM cohort study	5
External evaluation of population pharmacokinetic models for voriconazole in Chinese adult patients with hematological malignancy	5
The effect of tetrahydrocannabinol:cannabidiol oromucosal spray on cognition: a systematic review	5
Effect of SAcubitril/Valsartan on left vEntricular ejection fraction and on the potential indication for Implantable Cardioverter Defibrillator in primary prevention: the SAVE-ICD study	5
Population pharmacokinetics of cyclosporine A in pediatric patients with thalassemia undergoing allogeneic hematopoietic stem cell transplantation	5
Evaluation of vatiquinone drug-drug interaction potential in vitro and in a phase 1 clinical study with tolbutamide, a CYP2C9 substrate, and omeprazole, a CYP2C19 substrate, in healthy subjects	5
Correction to: Does evidence from RCTs suggest: SGLT2 inhibitors could not reduce myocardial infarction and stroke?	5
Reliability and validity of the Turkish version of the medication practical barriers to adherence questionnaire in patients with chronic diseases	5
A systematic review and meta-analysis of non-vitamin K antagonist oral anticoagulants vs vitamin K antagonists after transcatheter aortic valve replacement in patients with atrial fibrillation	5
Does ramadan fasting affect the therapeutic and clinical outcomes of warfarin? a systematic review and meta-analysis	5
Drug repositioning in the COVID-19 pandemic: fundamentals, synthetic routes, and overview of clinical studies	5
Sodium-glucose cotransporter 2 inhibitors and contrast-induced nephropathy risk: a meta-analysis	5
Use of a long-acting substitute in detoxification from benzodiazepines: safety (accumulation) problems and proposed mitigation procedure	5
Why not? Motivations for entering a volunteer register for clinical trials during the COVID-19 pandemic	5
Untapped options to reduce waste from blister packaging for tablets and capsules	5
Drug administration via feeding tubes—a procedure that carries risks: systematic identification of critical factors based on commonly administered drugs in a cohort of stroke patients	5
Direct oral anticoagulants and the risk of adverse clinical outcomes among patients with different body weight categories: a large hospital-based study	5
Utility of in silico prediction of target suppression for antibodies against soluble targets: static versus dynamic models	5
Linezolid pharmacokinetics: a systematic review for the best clinical practice	4
Prevention of contrast induced-acute kidney injury using coenzyme Q10 in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention	4
Evolution of adverse drug reactions reporting systems: paper based to software based	4
Long-acting B-2 agonists (LABA) or long-acting muscarinic antagonists (LAMA): which one may be the first option in group A COPD patients?	4
Comparative analysis of PIM criteria and drug labels in the elderly	4
Analysis of a medication discrepancy management platform in reducing medication discrepancy and influencing factors among elderly patients with polypharmacy	4
Lack of association between CYB5A gene rs1790834 polymorphism and the response to leflunomide in women with rheumatoid arthritis	4
Imprecision in adverse event reports following immunization against HPV in Japan and COVID-19 in the USA, UK, and Japan—and the effects of vaccine hesitancy and government policy	4
Evidence-based medication adherence among seniors in the first year after heart failure hospitalisation and subsequent long-term outcomes: a restricted cubic spline analysis of adherence-outcome relat	4
Potentially inappropriate medication use and the hospitalization rate among Thai elderly patients: a retrospective cohort study	4
Evaluation of drug interactions of saxagliptin with sildenafil in healthy volunteers	4
Association between glucagon-like peptide-1 receptor gene polymorphism and treatment response to GLP1R agonists in Chinese patients with type 2 diabetes: a prospective cohort study	4
Features and results availability of non-commercial Spanish COVID-19 trials: a systematic review of clinical trial registers and corresponding literature	4
Prevalence and clinical predictors of inappropriate direct oral anticoagulant dosage in octagenarians with atrial fibrillation	4
In silico evaluation of limited sampling strategies for individualized dosing of extended half-life factor IX concentrates in hemophilia B patients	4
Comparing AGS Beers 2019, STOPP version 2, and EU(7)-PIM list in Portuguese older adults in primary health care	4
Potential association between chia seeds use and low atazanavir trough concentrations in an HIV-infected patient	4
Drug–drug interaction of phenytoin sodium and methylprednisolone on voriconazole: a population pharmacokinetic model in children with thalassemia undergoing allogeneic hematopoietic stem cell transpla	4
Population pharmacokinetics of valproic acid in adult Chinese patients with bipolar disorder	4
Feasibility and safety of EGFR-TKI neoadjuvant therapy for EGFR-mutated NSCLC: A meta-analysis	4
Cost effectiveness of antihypertensive drugs and treatment guidelines	4
The pharmacokinetic interaction between nasally administered naloxone and the opioid remifentanil in human volunteers	4
Cost-utility analysis of a structured medication review compared to usual care in Parkinson’s disease	4
Incidence, characteristics, and risk factors of drug-associated muscle adverse reaction: a retrospective real-world study of inpatients	4
Association between the use of hormonal contraceptives and risk of gallstone disease	4
Why hospital-based healthcare professionals do not report adverse drug reactions: a mixed methods study using the Theoretical Domains Framework	4
Association of clozapine and norclozapine levels with patient and therapy characteristics—focus on interaction with valproic acid	4
Isopropyl alcohol inhalation versus 5-HT3 antagonists for treatment of nausea: a meta-analysis of randomised controlled trials	4
Effect of aspirin on incidence, recurrence, and mortality in prostate cancer patients: integrating evidence from randomized controlled trials and real-world studies	4
Fixed parameters in the population pharmacokinetic modeling of valproic acid might not be suitable: external validation in Chinese adults with epilepsy or after neurosurgery	4
Comparison of ticagrelor and clopidogrel on platelet function and prognosis in unstable angina	4
Prognostic effect of a vasopressin V2 receptor antagonist in acute congestive heart failure patients with hypoperfusion, the wet–cold pattern	4
Within-subject pharmacokinetic variability has a strong influence on individual exposure ratios in bioequivalence studies, hence on drug formulation interchangeability	4
Influence of N-acetyltransferase 2 (NAT2) genotype/single nucleotide polymorphisms on clearance of isoniazid in tuberculosis patients: a systematic review of population pharmacokinetic models	4
Restrictions on the use of placebo in new COVID-19 vaccine trials	4
Predictive factors associated with pemetrexed acute toxicity	4
Dihydropyrimidine dehydrogenase phenotype in peripheral blood mononuclear cells is related to adverse events of fluoropyrimidine-therapy	4
Drug information sources in professional work—a questionnaire study on physicians’ usage and preferences (the drug information study)	4
Correction to: Empagliflozin and colchicine in patients with reduced left ventricular ejection fraction following ST-elevation myocardial infarction: a randomized, double-blinded, three-arm parallel-g	4
Evaluation of Global trigger tool as a medication safety tool for adverse drug event detection—a cross-sectional study in a tertiary hospital	4
Risk of cardiovascular events according to the tricyclic antidepressant dosage in patients with chronic pain: a retrospective cohort study	4
Strategies to manage auxiliary pain medications in chronic pain trials: a topical review	3
Potentially inappropriate medications and cognitive performance: cross-sectional results from the ELSA–Brasil study	3
Safety evaluation of oral calcitonin-gene–related peptide receptor antagonists in patients with acute migraine: a systematic review and meta-analysis	3
Use of dipyrone during pregnancy and risk of congenital anomalies: a systematic review	3
Evaluation of drug-drug interactions of pemigatinib in healthy participants	3
Teplizumab: type 1 diabetes mellitus preventable?	3
The impact of age and renal function on the pharmacokinetics and protein binding characteristics of fludarabine in paediatric and adult patients undergoing allogeneic haematopoietic stem cell transpla	3
Linezolid-associated serotonin toxicity: a systematic review	3